Pulmonary embolism rule-out strategies using D-dimer guided by the YEARS algorithm and an age-adjusted cutoff: systematic review
DOI:
https://doi.org/10.36557/2674-8169.2026v8n2p1107-1127Keywords:
pulmonary embolism; D-dimer; YEARS; clinical probability.Abstract
Introduction: Safe diagnostic exclusion of pulmonary embolism (PE) in hemodynamically stable patients relies on integrating pretest clinical probability, D-dimer testing, and imaging. However, fixed D-dimer thresholds reduce operational efficiency—particularly in older adults—by increasing computed tomographic pulmonary angiography (CTPA) use. Age-adjusted D-dimer cutoffs and simplified algorithms such as YEARS have been proposed to optimize the trade-off between safety (low follow-up failure rates) and efficiency (less CTPA). Objective: to critically synthesize evidence on PE rule-out strategies using D-dimer guided by the YEARS algorithm and by an age-adjusted cutoff, focusing on clinical safety, diagnostic performance, and imaging utilization. Methods: systematic review conducted in accordance with PRISMA 2020, searching biomedical databases (e.g., PubMed/MEDLINE, Cochrane Library, and regional databases) using MeSH/DeCS terms related to PE, D-dimer, YEARS, age-adjustment, and clinical probability. Eligible studies included diagnostic management and/or accuracy studies applying YEARS and/or age-adjusted thresholds, with appropriate reference standards and/or clinical follow-up for thromboembolic events. Methodological quality was assessed using QUADAS-2. A narrative synthesis was performed without meta-analysis, extracting safety outcomes (follow-up events) and efficiency outcomes (CTPA avoidance). Conclusion: current evidence supports that adaptive D-dimer threshold strategies (YEARS, age-adjusted, and probability-adjusted approaches) can reduce CTPA utilization while maintaining acceptable safety in selected populations, with performance depending on the clinical setting, patient profile, and the acceptable residual-risk threshold.
Downloads
References
DUFFY, J. et al. Implementation of the YEARS algorithm to optimise pulmonary embolism diagnostic workup in the emergency department. BMJ Open Quality, v. 12, e002119, 2023. DOI: 10.1136/bmjoq-2022-002119. Disponível em: https://bmjopenquality.bmj.com/content/12/2/e002119.
KEARON, Clive et al. Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability. The New England Journal of Medicine, Boston, v. 381, n. 22, p. 2125-2134, 2019. DOI: 10.1056/NEJMoa1909159. Disponível em: https://www.nejm.org/doi/full/10.1056/NEJMoa1909159.
KLINE, Jeffrey A. et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. Journal of Thrombosis and Haemostasis, Oxford, v. 6, n. 5, p. 772-780, 2008. DOI: 10.1111/j.1538-7836.2008.02944.x. Disponível em: https://pubmed.ncbi.nlm.nih.gov/18318689/.
KONSTANTINIDES, Stavros V. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal, Oxford, v. 41, n. 4, p. 543-603, 2020. DOI: 10.1093/eurheartj/ehz405. Disponível em: https://academic.oup.com/eurheartj/article/41/4/543/5556136.
LE GAL, Grégoire; BOUNAMEAUX, Henri. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. Journal of Thrombosis and Haemostasis, v. 2, 2004. DOI: 10.1111/j.1538-7836.2004.00795.x. Disponível em: https://doi.org/10.1111/j.1538-7836.2004.00795.x.
LE GAL, Grégoire et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Annals of Internal Medicine, Philadelphia, v. 144, n. 3, p. 165-171, 2006. DOI: 10.7326/0003-4819-144-3-200602070-00004. Disponível em: https://pubmed.ncbi.nlm.nih.gov/16461960/.
LIM, Wendy et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Advances, Washington, v. 2, n. 22, p. 3226-3256, 2018. Disponível em: https://ashpublications.org/bloodadvances/article/2/22/3226/16134/.
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158). London: NICE, 2020. Atualizado em 02 ago. 2023. Disponível em: https://www.nice.org.uk/guidance/ng158.
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE). Age-adjusted D-dimer testing for suspected pulmonary embolism (PE). In: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158). London: NICE, 2020. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK556650/.
PAGE, Matthew J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, London, v. 372, n. 71, 2021a. DOI: 10.1136/bmj.n71. Disponível em: https://www.bmj.com/content/372/bmj.n71.
RIGHINI, Marc et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA, Chicago, v. 311, n. 11, p. 1117-1124, 2014. DOI: 10.1001/jama.2014.2135. Disponível em: https://jamanetwork.com/journals/jama/fullarticle/1841967.
SCHÜNEMANN, Holger J. et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, Oxford, v. 64, n. 4, p. 383-394, 2011. DOI: 10.1016/j.jclinepi.2010.04.026. Disponível em: https://www.jclinepi.com/article/S0895-4356(10)00295-6/fulltext.
STALS, M. A. M. et al. Ruling out pulmonary embolism across different healthcare settings: a systematic review and individual patient data meta-analysis. PLOS Medicine, 2022a. DOI: 10.1371/journal.pmed.1003905. Disponível em: https://doi.org/10.1371/journal.pmed.1003905.
STALS, M. A. M. et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups: A Systematic Review and Individual-Patient Data Meta-analysis. Annals of Internal Medicine, 2022b. DOI: 10.7326/M21-2625. Disponível em: https://www.acpjournals.org/doi/10.7326/M21-2625.
VAN DER HULLE, Tom et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. The Lancet, London, v. 390, n. 10091, p. 289-297, 2017. DOI: 10.1016/S0140-6736(17)30885-1. Disponível em: https://www.thelancet.com/article/S0140-6736(17)30885-1/fulltext.
VAN MAANEN, R. et al. YEARS clinical decision rule for diagnosing pulmonary embolism: a prospective diagnostic cohort follow-up study. BMJ Open, v. 15, e091543, 2025. DOI: 10.1136/bmjopen-2024-091543. Disponível em: https://doi.org/10.1136/bmjopen-2024-091543.
WHITING, Penny F.
et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine, Philadelphia, v. 155, n. 8, p. 529-536, 2011. DOI: 10.7326/0003-4819-155-8-201110180-00009. Disponível em: https://www.acpjournals.org/doi/10.7326/0003-4819-155-8-201110180-00009.
WELLS, Philip S. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management study. Annals of Internal Medicine, Philadelphia, v. 135, n. 2, p. 98-107, 2001. DOI: 10.7326/0003-4819-135-2-200107170-00010. Disponível em: https://pubmed.ncbi.nlm.nih.gov/11453709/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ana Julia Ferreira Serafim, Bruna Luciana Ferreira Portel Martins, Julia Rizzon Souza, Maria Eduarda Gahyva Schwabe, Mariane Sartoretto Tesk, Nájla Morais, Nicolas Carlos Nunes Rondon, Thales Ignácio Colina de Oliveira , Tony José de Souza, Viviane Vitória de Figueiredo

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



